Skip to main content

BioMedNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW), Partners Launch Proven Breakthrough Hair-Booster System in India

Jupiter Wellness (NASDAQ: JUPW), a wellness company focused on hair metabolism and skin therapies, in partnership with its regional distributors, has launched Cosmofix MinoxiBoost in India. JUPW’s distributors are Sanpellegrino Cosmetics Pvt Ltd and Cosmofix Technovation Pvt Ltd, which have exclusive distribution rights to the company’s patented hair-growth technology in 31 countries in Asia and the Middle East including India, the Philippines, Malaysia, Kuwait, Morocco and Saudi Arabia. According to the announcement, MinoxiBoost has been clinically proven to increase essential hair enzymes and is designed to be integrated into the daily minoxidil routine of people seeking increased hair growth. The announcement also noted that based on the distribution agreement, JUPW is entitled to receive royalties on all sales of MinoxiBoost as well as MinoxiClean, which is slated to be launched in the near future. A patented breakthrough hair-booster system, MinoxiBoost improves response to minoxidil, which is sold as Rogaine(R) and is the top-selling hair-growth product in the world. The collaboration between Jupiter Wellness, Sanpellegrino and Cosmofix Technovation is focused on bringing innovative products to the Indian market. “We are proud to join forces with Sanpellegrino Cosmetics and Cosmofix Technovation to launch MinoxiBoost in the world’s second most populous country,” said Jupiter Wellness CEO Brian John in the press release. “We are pleased to bring Indian consumers an innovative hair care solution that can significantly enhance their hair growth journey and is set to revolutionize the hair care industry by enhancing the effectiveness of minoxidil.”

To view the full press release, visit https://ibn.fm/d8Xqx

About Jupiter Wellness Inc.

Jupiter Wellness is a diversified company that supports health and wellness by researching and developing over-the-counter (“OTC”) products and intellectual property. The company’s product pipeline addresses a range of conditions, including hair loss, psoriasis and vitiligo. Revenue is generated through the sales of OTC and consumer products, and licensing royalties. For additional information about this company, please visit www.JupiterWellnessInc.com.

NOTE TO INVESTORS: The latest news and updates relating to JUPW are available in the company’s newsroom at https://ibn.fm/JUPW

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.